|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
5/7/24 Ligand Pharmaceuticals Inc. 8-K:2,9 5/7/24 11:339K
2/27/24 Ligand Pharmaceuticals Inc. 8-K:2,9 2/27/24 11:420K
11/13/23‡ Ligand Pharmaceuticals Inc. 8-K/A:2,9 11/9/23 11:437K
11/8/23 Ligand Pharmaceuticals Inc. 8-K:2,9 11/8/23 11:433K
8/8/23 Ligand Pharmaceuticals Inc. 8-K:2,9 8/8/23 11:417K
5/4/23 Ligand Pharmaceuticals Inc. 8-K:2,9 5/4/23 11:389K
2/22/23 Ligand Pharmaceuticals Inc. 8-K:2,9 2/22/23 11:455K
11/7/22 Ligand Pharmaceuticals Inc. 8-K:2,9 11/7/22 11:472K
8/8/22 Ligand Pharmaceuticals Inc. 8-K:2,9 8/8/22 11:502K
5/4/22 Ligand Pharmaceuticals Inc. 8-K:2,9 5/4/22 11:421K
2/17/22 Ligand Pharmaceuticals Inc. 8-K:2,9 2/17/22 11:433K
11/9/21 Ligand Pharmaceuticals Inc. 8-K:2,9 11/9/21 11:424K
7/29/21 Ligand Pharmaceuticals Inc. 8-K:2,9 7/29/21 11:422K
5/3/21 Ligand Pharmaceuticals Inc. 8-K:2,9 5/3/21 13:379K
2/3/21 Ligand Pharmaceuticals Inc. 8-K:2,9 2/3/21 13:480K
10/30/20 Ligand Pharmaceuticals Inc. 8-K:2,9 10/30/20 13:449K
10/20/20 Ligand Pharmaceuticals Inc. 8-K:2,7,9 10/20/20 13:16M
8/3/20 Ligand Pharmaceuticals Inc. 8-K:2,9 8/3/20 13:578K
5/6/20 Ligand Pharmaceuticals Inc. 8-K:2,9 5/6/20 13:528K
4/6/20 Ligand Pharmaceuticals Inc. 8-K:2,8 4/6/20 12:175K
____________ | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | ¹ | Filing/Form Type: | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. |
|